Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016:2016:2373902.
doi: 10.1155/2016/2373902. Epub 2016 Mar 10.

Cytogenetically Unrelated Clones in Acute Myeloid Leukemia Showing Different Responses to Chemotherapy

Affiliations

Cytogenetically Unrelated Clones in Acute Myeloid Leukemia Showing Different Responses to Chemotherapy

Kohei Kasahara et al. Case Rep Hematol. 2016.

Abstract

We report a case of acute myeloid leukemia (AML) with two cytogenetically unrelated clones. The patient was a 45-year-old male who was diagnosed with acute monoblastic leukemia (AMoL). Initial G-band analysis showed 51,XY,+6,+8,inv(9)(p12q13)c,+11,+13,+19[12]/52,idem,+Y[8], but G-band analysis after induction therapy showed 45,XY,-7,inv(9)(p12q13)c[19]/46,XY,inv(9)(p12q13)c[1]. Retrospective FISH analysis revealed a cryptic monosomy 7 clone in the initial AML sample. The clone with multiple trisomies was eliminated after induction therapy and never recurred, but a clone with monosomy 7 was still detected in myelodysplastic marrow with a normal blast percentage. Both clones were successfully eliminated after related peripheral blood stem cell transplantation, but the patient died of relapsed AML with monosomy 7. We concluded that one clone was de novo AMoL with chromosome 6, 8, 11, 13, and 19 trisomy and that the other was acute myeloid leukemia with myelodysplasia-related changes(AML-MRC) with chromosome 7 monosomy showing different responses to chemotherapy. Simultaneous onset of cytogenetically unrelated hematological malignancies that each have a different disease status is a rare phenomenon but is important to diagnose for a correct understanding of the disease status and for establishing an appropriate treatment strategy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(a) and (b) May-Giemsa staining of a bone marrow smear before and after induction therapy. (a) Monoblasts (left lower panel) consisted of 82.4% of bone marrow mononuclear cells at diagnosis. (b) Blast population significantly decreased after induction therapy, but there were background differentiated cells showing a dysplastic feature including hypogranular neutrophils (left lower panel) and discrete multinuclear megakaryocytes (right lower panel). (c) and (d) G-banding of bone marrow before and after induction therapy. Each panel showed a dominant karyotype at each point. (c) In the initial sample, all cells were abnormal, with a dominant clone showing multiple trisomies (red arrows). (d) The clone with multiple trisomies completely disappeared, but the monosomy 7 (blue arrow) clone was unmasked after induction therapy. All cells showed a pericentric inversion of chromosome 9 (green arrow), a known normal variant in the general population.

Similar articles

Cited by

References

    1. Han J. Y., Theil K. S., Hoeltge G. Frequencies and characterization of cytogenetically unrelated clones in various hematologic malignancies: seven years of experiences in a single institution. Cancer Genetics and Cytogenetics. 2006;164(2):128–132. doi: 10.1016/j.cancergencyto.2005.07.013. - DOI - PubMed
    1. Furuya T., Morgan R., Sandberg A. A. Cytogenetic biclonality in malignant hematologic disorders. Cancer Genetics and Cytogenetics. 1992;62(1):25–28. doi: 10.1016/0165-4608(92)90032-4. - DOI - PubMed
    1. Johansson B., Billström R., Broberg K., et al. Cytogenetic polyclonality in hematologic malignancies. Genes Chromosomes and Cancer. 1999;24(3):222–229. doi: 10.1002/(SICI)1098-2264(199903)24:3<222::AID-GCC7>3.0.CO;2-A. - DOI - PubMed
    1. Pedersen-Bjergaard J., Timshel S., Andersen M. K., Andersen A.-S. T., Philip P. Cytogenetically unrelated clones in therapy-related myelodysplasia and acute myeloid leukemia: experience from the Copenhagen Series updated to 180 consecutive cases. Genes Chromosomes and Cancer. 1998;23(4):337–349. doi: 10.1002/(SICI)1098-2264(199812)23:4<337::AID-GCC9>3.0.CO;2-L. - DOI - PubMed
    1. Raimondi S. C., Pui C.-H., Head D. R., Rivera G. K., Behm F. G. Cytogenetically different leukemic clones at relapse of childhood acute lymphoblastic leukemia. Blood. 1993;82(2):576–580. - PubMed

LinkOut - more resources